Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of platelet aggregation of ticagrelor 180 mg, clopidogrel 600 mg loading dose and prasugrel 60 mg loading dose and correlation of response of platelet aggregation to CYP2C19*2, *3, and *17 single nucleotide polymorphisms in Thai patients who planned undergoing coronary angiography.

Trial Profile

Comparison of platelet aggregation of ticagrelor 180 mg, clopidogrel 600 mg loading dose and prasugrel 60 mg loading dose and correlation of response of platelet aggregation to CYP2C19*2, *3, and *17 single nucleotide polymorphisms in Thai patients who planned undergoing coronary angiography.

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Coronary disorders
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 18 Jul 2017 Status changed from recruiting to active, no longer recruiting.
    • 05 Jun 2017 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top